Multiplex blood-test and Magnetic Resonance Imaging (MRI) for prostate cancer screening: Results from the 2nd screening round in the STHLM3-MRI trial

被引：0
|
作者：
Discacciati, A. [1 ]
Abbadi, A. [1 ]
Chandra, J. [2 ]
Annerstedt, M. [3 ]
Glaessgen, A. [4 ]
Carlsson, S. [5 ]
Jaderling, F. [5 ]
Gronberg, H. [1 ]
Eklund, M. [1 ]
Nordstrom, T. [1 ]
机构：
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[2] Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Stockholm, Sweden
[3] Dept Urol, C Med, Stockholm, Sweden
[4] Unilabs, Dept Pathol, Stockholm, Sweden
[5] Karolinska Inst, Dept Mol Med, Stockholm, Sweden
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0664
引用
收藏
页码：S1611 / S1611
页数：1
相关论文
共 37 条
  • [31] Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study (vol 82, pg 12, 2022)
    Hao, Shuang
    Heintz, Emelie
    Ostensson, Ellinor
    Discacciati, Andrea
    Jaderling, Fredrik
    Gronberg, Henrik
    Eklund, Martin
    Nordstrom, Tobias
    Clements, Mark S.
    EUROPEAN UROLOGY, 2022, 82 (01) : E21 - E21
  • [32] Cost-effectiveness of multiparametric magnetic resonance imaging and MRI-guided biopsy in a population-based prostate cancer screening setting using a micro-simulation model
    Getaneh, Abraham M.
    Heijnsdijk, Eveline A. M.
    de Koning, Harry J.
    CANCER MEDICINE, 2021, 10 (12): : 4046 - 4053
  • [33] A Head-to-head Comparison of Prostate Cancer Diagnostic Strategies Using the Stockholm3 Test, Magnetic Resonance Imaging, and Swedish National Guidelines: Results from a Prospective Population-based Screening Study
    Walden, Mauritz
    Aldrimer, Mattias
    Lagerlof, Jakob Heydorn
    Eklund, Martin
    Gronberg, Henrik
    Nordstrom, Tobias
    Palsdottir, Thorgerdur
    EUROPEAN UROLOGY OPEN SCIENCE, 2022, 38 : 32 - 39
  • [34] Prostate Cancers in the Prostate-specific Antigen Interval of 1.8-3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial
    Moller, Fredrik
    Mansson, Marianne
    Wallstrom, Jonas
    Hellstrom, Mikael
    Hugosson, Jonas
    Godtman, Rebecka Arnsrud
    EUROPEAN UROLOGY, 2024, 86 (02) : 95 - 100
  • [35] Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: Results from a prospective study
    Renard-Penna, Raphaele
    Roupret, Morgan
    Comperat, Eva
    Ayed, Amine
    Coudert, Mathieu
    Mozer, Pierre
    Xylinas, Evanguelos
    Bitker, Marc-Olivier
    Grenier, Philippe
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (04) : 448 - 454
  • [36] TISSUE CHARACTERIZATION BY MAGNETIC-RESONANCE SPECTROSCOPY AND IMAGING - RESULTS OF A CONCERTED RESEARCH-PROJECT OF THE EUROPEAN-ECONOMIC-COMMUNITY .3. TRIAL OF MODIFICATIONS TO EUROSPIN MRI TEST OBJECTS
    LERSKI, RA
    MAGNETIC RESONANCE IMAGING, 1993, 11 (06) : 835 - 839
  • [37] Comparing 18F-FDG positron emission tomography (PET) and breast magnetic resonance imaging (MRI) to predict pathological complete response (pCR) and 3-year invasive disease-free survival (3-y iDFS) in patients (pts) with HER2+early breast cancer (EBC): An unplanned exploratory analysis of PHERGain trial
    Perez Garcia, Jose Manuel
    Cortes, Javier
    Ruiz-Borrego, Manuel
    Stradella, Agostina
    Bermejo, Begona
    Escriva-de-Romani, Santiago
    Calvo, Lourdes
    Gebhart, Geraldine
    Kerrou, Khaldoun
    Garcia-Mosquera, Juan Jose
    Gion, Maria
    Antonarelli, Gabriele
    Lopez-Montero, Laura
    Rodriguez-Morato, Jose
    Mina, Leonardo
    Sampayo-Cordero, Miguel
    Llombart-Cussac, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
1234